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ABSTRACT
The Beijing genotype comprises a highly disseminated strain type that is frequently associated with multidrug resistant
(MDR) tuberculosis (TB) and increased transmissibility but, countries such as Portugal and Guinea-Bissau fall outside the
regions phylogeographically associated with this specific genotype. Nevertheless, recent data shows that this genotype
might be gradually emerging in these two countries as an underlying cause of primary MDR-TB. Here, we describe the
emergence of Mycobacterium tuberculosis Beijing strains associated with MDR-TB in Portugal and Guinea-Bissau
demonstrating the presence of the well described superclusters 100-32 and 94-32 in Portugal and Guinea-Bissau,
respectively. Genome-wide analysis and comparison with a global genomic dataset of M. tuberculosis Beijing strains,
revealed the presence of two genomic clusters encompassing isolates from Portugal and Guinea-Bissau, GC1 (n = 121)
and GC2 (n = 39), both of which bore SNP signatures compatible with the 100-32/B0/W148 and 94-32/Central Asia
Outbreak clades, respectively. Moreover, GC2 encompasses a cross-border cluster between Portugal, Guinea-Bissau
and Brazil thus supporting migration-associated introduction of MDR-TB and subsequent clonal expansion at the
community-level. The comparison with global Beijing datasets demonstrates the global reach of the disease and its
complex dissemination across multiple countries while in parallel there are clear microevolutionary trajectories
towards extensively drug resistant TB.
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Introduction
Originally described by van Soolingen et al. in 1995,
Mycobacterium tuberculosis Beijing lineage has
shown a variable association with drug resistance
coupled with a well-documented transmissibility
and ability to cause tuberculosis (TB) outbreaks [1].
In the 1990s, Beijing strains became widely known
as the underlying cause of a major New York multi-
drug-resistant (MDR)-TB outbreak among patients
co-infected with the Human Immunodeficiency
Virus (HIV) [2]. Other outbreaks involving drug
resistant Beijing strains are often described in
different regions throughout the globe [3,4]. This
specific and widespread genotype was initially
thought to have emerged in North-Central China
more than one thousand years ago but, recent esti-
mates point to Beijing lineage split approximately
thirty thousand years ago in southern East Asia
[5,6]. At the immunopathological level, the Beijing
lineage has shown several potential selective advan-
tages, particularly its “modern” sub-branch (i.e.
strains harboring a IS6110 at the NTF locus and
mutT4 codon 48 CGG > GGG substitution) which
were shown in some studies to be associated with a
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reduced proinflammatory response and an increased
virulence on mouse models of infection [7,8].
In Portugal, MDR-TB has been a major cause of
public health concern particularly in the metropolitan
area surrounding Lisbon. This concern is mainly due
to two major monophyletic clades of the Latin Ameri-
can and Mediterranean (LAM) lineage (Lisboa3 and
Q1), highly associated with MDR-TB, but also exten-
sively drug resistant (XDR)-TB [9]. Despite its well-
documented transmissibility and ability to cause TB
outbreaks, Beijing strains are seldom isolated in the
country [3,4,10].
Nevertheless, over the last 10 years we have been
observing an increasing number of MDR-TB cases
associated with Beijing strains (unpublished data).
Recently, we developed CPLP-TB (http://cplp-tb.ff.
ulisboa.pt), an online database aimed at tracking clones
ofM. tuberculosis expanding over Portuguese-speaking
countries [11]. Presently, CPLP-TB contains nine and
eight Beijing isolates from Portugal and Guinea-Bissau,
respectively, with available 24-loci Mycobacterial Inter-
spersed Repetitive Unit-Variable Number of Tandem
Repeat (MIRU-VNTR) profiles. In Guinea-Bissau, the
emergence of Beijing strains associated with MDR-
TB was previously reported by us although the route
driving the emergence and spread of such strains to
this country was unclear [12].
Herein, we explore the source of the MDR-TB Beij-
ing genotypes in both Portugal and Guinea-Bissau and
unveil novel and previously uncharacterized routes for
their emergence.
Methods
Clinical isolates and drug susceptibility testing
A total of seventeen M. tuberculosis clinical isolates
belonging to the Beijing genotype as determined by
spoligotyping were selected. From these, eight isolates
were recovered from patients followed at the Hospital
Raoul Follereau in Bissau, Guinea-Bissau, while the
remaining nine isolates were obtained from patients
at laboratories and hospitals across the Lisbon Health
Region in Portugal between 2008 and 2014.
All isolates were subjected to susceptibility testing to
all five first-line drugs by the BACTEC™MGIT™ 960
System (Becton Dickinson Diagnostic Systems, Sparks,
MD, USA) using standardized critical concentrations.
Genotyping and cluster identification
Twenty-four-loci MIRU-VNTR typing was carried out
by multiplex amplification procedure described by
Supply et al [13]. Amplicon size determination was
performed by capillary electrophoresis on an ABI
3130 Genetic Analyzer (Applied Biosystems®, Foster
City, CA, USA) using a custom ROX-labelled
molecular weight marker, MapMarker®1200 (Bioven-
tures®, Murfreesboro, TN, USA), with 25 bands sized
between 100 and 1200 bp.
Spoligotyping was performed by a single-tube multi-
plex PCR amplification of 43 spacer regions of the
direct repeat (DR) locus using oligonucleotide primers
DRa (5′-Biotin-GGTTTTGGGTCTGACGAC-3′) and
DRb (5′-CCGAGAGGGGACGAAAC-3′) and 20 ng
of genomic DNA. Amplicons were reverse hybridized
on a membrane with amino-linked immobilized probes
for each spacer as described previously by Kamerbeek
et al. Detection was performed using the ECL® Chemi-
luminescence Detection System (GE Healthcare®, Cle-
veland, OH, USA) as per the manufacturer’s
instructions. Spoligotyping profiles were assigned to
lineage, clade and shared international type (SIT)
using the rules described in SITVITWEB and SITVIT2
international databases [10,14,15].
A comparative genotypic profile analysis was carried
out including a total of 5482 isolates and 24-loci
MIRU-VNTR profiles assembled from three large
global studies, along with publicly available metadata
[16–18]. Hierarchical clustering analysis was con-
ducted in R statistical software using the hclust func-
tion and clusters defined as groups of two or more
isolates sharing identical 24-loci MIRU-VNTR profiles.
MtbC15-9 type classification was performed using the
MIRU-VNTRplus online database [19]. The Hunter-
Gaston index of diversity was computed as described
previously [20].
Whole genome sequencing and bioinformatic
analysis
Whole genome sequencing (WGS) was carried out
using an Illumina HiSeq 2500 paired-end (100/
150 bp) platform. Single nucleotide polymorphisms
(SNPs) were obtained by mapping raw sequence
reads to the M. tuberculosis H37Rv genome (GenBank
Ref. NC000962.3) using BWA-mem and by variant
calling using the SAMtools/GATK software suites in
established pipelines [9,21,22]. A comparison against
publicly available sequence data was carried out for
all sequenced isolates against 5296 Lineage 2
M. tuberculosis strains with Illumina short-read
sequence data available on the European Nucleotide
Archive (ENA) until July 2017 (see Supplementary
Table S1 for full list of ENA accessions) and, for
which SNPs were then called using the same bioinfor-
matics pipeline as above. SNP sites or samples having
an excess of 10% missing calls were removed from
the analysis [21]. SNP sites within PE/PPE genes or
those occurring at low mappability regions were also
excluded from the analysis. The final dataset was com-
posed of a total of 5180 isolates and 67,846 SNPs.
Sequence data generated in this study is available on
ENA under study accession ERP002611.
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Genomic clustering was evaluated under both a five
and twelve SNP distance threshold using R and the ape
package [23]. A maximum-likelihood phylogenetic tree
was constructed for the complete dataset using Fas-
tTree with a Generalised Time Reversible (GTR)
model (Supplementary Figure S1) [24]. Additional
maximum-likelihood phylogenetic trees were con-
structed using PhyML as implemented in Seaview for
the genomic clusters found under a maximum distance
of twelve SNPs. The phylogenetic context of the non-
clustered isolates from Portugal or Guinea-Bissau was
reconstructed by comparison with isolates within 100
SNPs. The best-fit nucleotide substitution models for
each dataset were evaluated using the R package phan-
gorn. The GTR model allowing across site rate vari-
ation and invariable sites was found to be the best-fit
model for the GC1 (negative Log-likelihood:
99341.88), GC2 (negative Log-likelihood: 93879.79)
and the GW000065 phylogenetic context (negative
Log-likelihood: 100664.40); the GTR model allowing
for invariable sites were found as the best-fit model
for the PT000095 (negative Log-likelihood: 96291.71)
and PT000025 (negative Log-likelihood: 94204.24)
phylogenetic datasets. Tree visualization and annota-
tion was performed using the Interactive Tree of Life
tool [25]. A map showing the geographical dispersion
of genomic clusters of interest was constructed using
Microreact [26].
Minimum spanning trees (MSTs) were constructed
using the goeBURST/Phyloviz software (available at
http://online2.phyloviz.net) [27].
Results
Emergence of Beijing family MDR-TB in Portugal
and Guinea-Bissau is associated with distinct
superclusters
To understand the dynamics of emergence and trans-
mission of MDR-TB associated with the Beijing geno-
type in Portugal and Guinea-Bissau, we analysed
seventeen Beijing isolates from Portugal (n = 9) and
Guinea-Bissau (n = 8), all of which recently character-
ized in the scope of the CPLP-TB database. The public
health importance of these strains in both countries is
noteworthy as 7/9 and 7/8 of these isolates in Portugal
and Guinea-Bissau, respectively, are MDR-TB strains
(Table 1). However, no links between the Portuguese
and Guinean Beijing strains were found except at the
12-loci MIRU-VNTR set (Table 1, Supplementary
Table S2). In Portugal, the nine Beijing strains yielded
seven distinct profiles (two clusters of two isolates,
each; and five non-clustered isolates) (Table 1). In Gui-
nea-Bissau, five distinct profiles were observed encom-
passing two MIRU-VNTR clusters with two and three
isolates, respectively, and three non-clustered isolates
(Table 1). Regarding the clustered isolates, a classical Ta
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epidemiological survey approach failed to find epide-
miological links between patients, except for two
patients (P16 and P17) which are of two siblings shar-
ing the same household. Interestingly, both patients are
Portuguese nationals for which no further TB contacts
were identified and, neither had any prior history of
travelling outside the country.
Except for cases directly linked with immigrants,
which is not relevant in the Guinea-Bissau dataset
since all patients were of Guinean nationality, the
absence of additional transmission clusters with estab-
lished epidemiological links render unknown the
routes by which MDR-TB Beijing strains are being
introduced. To identify links with other Beijing clus-
ters, we compared the genotypic profiles of all seven-
teen clinical isolates included in this study against a
global dataset of 5,482 isolates assembled from three
large studies [16–18]. The comparison against this
dataset yielded a total of 1,848 distinct profiles (Hun-
ter-Gaston Index of Diversity, h = 0.9812). Four
cross-border clusters, comprising six out of the nine
Portuguese isolates, were identified matching
MtbC15-9 type 100-32 (n = 302; 2 Portuguese [PT] iso-
lates); 2083-32 (n = 18; 1 PT isolate); 4737–32 (n = 5; 2
PT isolates); and, 9387–32 (n = 3; 1 PT isolate) (Table
2). For Guinea-Bissau strains, two cross-border clusters
were detected (n = 5) matching MtbC15-9 type 94-32
(n = 576; 3 Guinea-Bissau [GW] isolates) and 9124-
32 (n = 6; 2 GW isolates) (Table 2).
WGS enables high-resolution clustering
snapshots of cross-border superclusters and the
detection of novel clustering between Portugal
and Guinea-Bissau
To obtain a more resolved snapshot, we sequenced the
genomes of 14 clinical isolates (Guinea-Bissau, n = 8;
Portugal, n = 6) and compared them to 5,296 Lineage
2 strains available on ENA until July 2017 (Supplemen-
tary Table S1). The final dataset, after removal of low
coverage samples and those having an excess of miss-
ing calls was composed of 5,181 isolates (including
M. tuberculosis H37Rv as an outgroup strain) and
67,846 SNP sites. The global phylogenetic tree obtained
for the entire dataset along with the examination of
drug resistance genotypes showed a wide distribution
and a high predominance of isolates showing a muta-
tional profile compatible with MDR-TB (n = 1,447)
and XDR-TB (n = 155) (Supplementary Figure S1).
Moreover, the overall tree structure is consistent with
multiple emergence of drug resistance and closely
grouped clusters of MDR-TB.
The genomic clustering analysis using a maximum
distance of 12 SNPs [23] enabled the identification of
two genomic clusters (GC1 and GC2) associated with
nine out of the 14 initially sequenced strains (Table
1). GC2 (partially depicted in Figure 1 see
Supplementary Figure S2 for the full MST) encom-
passes a total of 39 isolates including seven isolates
sequenced in this study, all which from Guinea-Bissau.
Interestingly, this cluster also comprises two additional
isolates fromGuinea-Bissau and another from Portugal
(Figure 1). Further cluster discrimination using a five
SNP threshold showed that all isolates from Guinea-
Bissau herein studied plus two isolates also from Gui-
nea-Bissau, one from Portugal and one from Brazil
formed a more restricted genomic cluster (GC2.1)
that comprised a monophyletic sub-branch within
GC2 that is parallel to other sub-branches that encom-
pass strains circulating mostly in Russia and on other
neighbouring countries such as Georgia, Moldova or
Azerbaijan. The topological structure of the tree is
therefore suggestive of dissemination from these
regions towards Guinea-Bissau, Portugal and Brazil.
All GC2 harboured the sigE silent mutation at codon
98 (genome position 1364706, G > A), associated with
type 94-32, which suggests possible descent from this
cluster with concomitant divergence at the MIRU-
VNTR loci (Figure 2) [28]. More specifically, all GC2
strains also bore the intergenic specific SNPs for the
Central Asia Outbreak specific sub-branch of the 94-
32 type [16].
The largest genome-wide-based cluster (GC1; par-
tially depicted in Figure 1 see Supplementary Figure
S2 for the full MST) was comprised of 121
M. tuberculosis Beijing isolates and included three iso-
lates sequenced in this study (PT000078, PT000080
and PT000013). The first two clinical isolates belong
to the two siblings (P16 and P17) with unknown TB
contacts. Notably, WGS data showed these samples
to be extremely close (one SNP difference) to a pre-
viously undetected isolate in Portugal three years
before. An epidemiological investigation showed that
the latter was obtained from an imprisoned Eastern
European immigrant. No epidemiological link could
be established between the imprisoned patient and
the siblings, except for the fact that the husband of
one of the siblings worked as a prison guard and was
often responsible for transportation of imprisoned
individuals; however this prison guard was never diag-
nosed with TB. The third isolate (PT000013) recovered
from a Moldova immigrant in Portugal was also part of
this large transmission network and genetically close
(≤5 SNPs) to isolates originating from Moldova and
Tajikistan. GC1 sub-clustering under a five SNP
threshold confirmed the genomic clustering of the sib-
lings with the imprisoned patient with the latter assum-
ing a basal positioning to this monophyletic sub-cluster
(GC1.1; Figure 2), while the PT000013 isolate was also
found to be part of a monophyletic cluster (GC1.2;
Figure 2) composed of five additional isolates from
Tajikistan (n = 4) and Moldova (n = 1). These findings
corroborate, on the one hand, that the dissemination of
strains leading to PT000078 and PT000080 result from
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the clonal expansion of MDR-TB Beijing isolates in
Portugal but that, on the other hand, strains belonging
to this same cluster are thought to have disseminated
from former Soviet states towards Eastern Europe
and Western Europe, therein represented by Portugal.
All strains in this GC were positive for the kdpD
Table 2. MIRU-VNTR (24-loci) obtained by comparison against a global Beijing dataset.
Cluster
MtbC15-9
CPLP-TB
Cluster
Total
isolates in
cluster
No. of
isolates from
Portugal
No. of isolates
from Guinea-
Bissau
Distribution per country of
Isolation > 5% (%)a
No. drug resistant
isolates in cluster (n)
a Commenta
94-32 GW-02 576 0 3 Uzbekistan = 25; Kazakhstan =
25; Russia = 9.4; Germany =
5.7; Turkmenistan = 5.6
Susc = 56; non-MDR
= 88; MDR = 317;
XDR = 8; nd = 107
Russian/Asian Clone
CC1 (RFLP-IS6110 A0
cluster)
100-32 PT-02 302 2 0 Russia = 28.5; Lithuania = 21.9;
Germany = 7.9
Susc = 8; non-MDR
= 26; MDR = 162;
nd = 98
Russian B0/148
2083-32 NC 18 1 0 n.s. non-MDR = 3; nd =
15
Highly prevalent in
Vietnam (n = 11/18)
9124-32 GW-01 6 0 2 n.s MDR = 5; nd = 1 Detected on Georgia
(n = 1), Poland (n =
1) and Russia (n = 2)
4737-32 PT-06 5 2 0 n.s MDR = 4; nd = 1 Armenia (n = 1),
Lithuania (n = 1) and
Russia (n = 1)
9387-32 NC 3 1 0 n.s MDR = 1; nd = 2 Beyond Portugal, only
detected in South
Africa (n = 2)
a Distribution according to global dataset assembled from Merker et al. [16], Skiba et al. [17] and Yin et al. [18].
n.s. – not significant due to the small number of isolates, see Comment column.
Figure 1. Genomic Clusters (GC) 1 and 2 comprising isolates characterized in the present study and herein defined as strains/nodes
within 12 SNPs of distance between each other. Each GC is here partially represented as a Minimum Spanning Tree (MST) as to
highlight nodes/strains closer to the analysed Beijing clinical isolates from Portugal and Guinea-Bissau (see Supplementary Figure
S2 for full MSTs). Lines connecting each node represent a link of ≤12 SNPs where each dot represents the genetic distance corre-
sponding to one SNP; lines depicted in black and grey represent distances ranging between 1–5 and 7–12 SNPs, respectively. GC1
comprises 121 isolates (displayed in a truncated form that highlights the positioning of Beijing strains isolated in Portugal) and
includes isolates PT000078, PT000080 (both representing a known transmission case among the same household and involving
two siblings, MtbC15-9 type 4737-32) and PT000013. PT000078 and PT000080 whose patients had no history of travel and of
known TB contacts, were found to be in proximity with an imprisoned immigrant from Eastern Europe (ERR1034819), which is
eight SNPs apart from another undetected immigrant from Eastern Europe in Portugal (ERR1034838). PT000013 pertains to a Mol-
dovan immigrant in Portugal and is herein linked to an isolate originating from Moldova, seven years after this case has been
detected in Portugal and is 3–4 SNPs apart of cases detected in Tajikistan. GC1 thus highlight the epidemiological impact and emer-
gence of MDR-TB strains belonging to this GC that appear to originate from a complex transmission network that mainly spans
across former Soviet states as well as its successful spread outside its endemic settings. GC2 depicts a cross-border cluster of pre-
viously unlinked cases between Portugal, Guinea-Bissau and Brazil that are also linked (≤12 SNPs) with isolates from former Soviet
states. Overall, the high resolution offered by whole genome sequencing enabled the identification of previously epidemiologically
unlinked cases and the identification of new routes for the spread of MDR-TB Beijing strains.
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binucleotide deletion marker for the Russian B0/W148,
part of the MIRU-VNTR 100-32 supercluster (Figure
2) [16,29]. Albeit belonging to MIRU-VNTR type
4737-32, PT00078 and PT00080 also bear this latter
genetic marker highlighting its likely descent from
100-32 supercluster. In comparison to GC2, GC1
showed a more widespread distribution across Europe
(Figure 2).
For non-clustered isolates GW000065, PT000095,
PT000025 and PT000242, the respective phylogenetic
contexts were investigated by examining the topologi-
cal structure of the phylogenetic trees constructed for
isolates within 100 SNPs of these isolates (Figure 3).
PT000242 and PT000025 were part of a sub-branch
of sublineage 2.2.1 that is parallel to strains isolated
in China and Vietnam. PT000095 is also phylogeneti-
cally positioned closer to strains circulating in Eastern
hemisphere countries such as Vietnam and Singapore.
Lastly, the GW000065 isolate from Guinea-Bissau is
part of a sub-branch of sublineage 2.2.1 that appears
to be disseminating in Africa and is parallel to other
sub-branches mostly found in Vietnam which also
suggests dissemination to Africa from the Eastern
part of the globe (Figure 3).
Figure 2. Maximum-likelihood based phylogenetic trees for GC1 and GC2encompassing 121 and 39 clinical isolates, respectively.
The global phylogenetic tree is shown annotated with: tip colours for GC1 (red) and GC2 (yellow) isolates; a first inner colour strip
highlighting isolates sequenced in this study from Portugal (blue) and Guinea-Bissau (green); a second colour strip highlighting
genotypic based classification of isolates as susceptible (green), any drug resistance other than MDR-/XDR-TB (yellow), MDR-TB
(red) and, XDR-TB (dark red); a third colour strip highlights sub-clusters at the five SNP distance threshold: GC1.1 (light blue),
GC1.2 (red) and GC2.1 (yellow); sublineage and country of isolation; most common drug resistance associated mutations; and, pres-
ence of kdpD binucleotide deletion marker for the Russian B0/W148 (blue triangles) and the sigE silent mutation at codon 98 associ-
ated with type 94-32 (green triangles). A map illustrates the geographical dissemination of GC1 (red) and GC2 (yellow) across Asia,
Europe, Africa and South America.
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Figure 3. Maximum-likelihood based phylogenetic trees illustrating the phylogenetic context surrounding the non-clustered iso-
lates GW000065, PT000095, PT000025 and PT000242. Three phylogenetic trees are shown annotated with: a first inner colour strip
highlighting isolates sequenced in this study from Portugal (blue) and Guinea-Bissau (green); a second colour strip highlighting
genotypic based classification of isolates as susceptible (green), any drug resistance other than MDR/XDR-TB (yellow), MDR-TB
(red) and, XDR-TB (dark red); sublineage and country of isolation; most common drug resistance associated mutations; and, pres-
ence of kdpD binucleotide deletion marker for the Russian B0/W148 (blue triangles) and the sigE silent mutation at codon 98 associ-
ated with type 94-32 (green triangles).
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Molecular basis of resistance within GC1 and
GC2 reveals multiple evolutionary trajectories
towards resistance amplification and XDR-TB
We examined the molecular basis of resistance within
the GCs herein detected (Table 3). All isolates in
GC2 (n = 39) bore the classical katG S315T, rpoB
S450L and rpsL K43R mutations associated with iso-
niazid (INH), rifampicin (RIF) and streptomycin
(STR) resistance, respectively; embB M306V mutation
was putatively associated with EMB resistance in 37
isolates, 11 of which corresponding to the Guinea-Bis-
sau/Portugal/Brazil sub-branch of GC2 concomitantly
showed the embA C-16G mutation; and, a D63A
mutation on pncA potentially conferring PZA resist-
ance was found in the latter eleven isolates. Further-
more, a frameshift ethA mutation (182delG) and a
thyX promoter mutation (C-16T) were also detected
among the same eleven GC2 isolates which, is therefore
potentially linked with ETH and PAS resistance,
respectively.
Contrarily to GC2, GC1 (n = 121) exhibited a
remarkably higher mutational diversity associated
with drug resistance. Nevertheless, two mutations
were common across all GC1 isolates: rpsL K43R and
katG S315T. Considering the three GC1 isolates
sequenced in this study, all possessed a rpoB S450L
mutation but diverged on the mutational profile of
other loci: the siblings P16 and P17 isolates’ both
showed embB M306I, rpoB V496A, and a single
nucleotide deletion on ethA (887delA); the remaining
isolate possessed a pncA D63A mutation. Globally,
GC1 isolates showed 98 distinct mutations on drug
resistance associated loci, and 4/121 showed muta-
tional profiles compatible with XDR-TB (Figure 2).
Associated with PZA resistance, the pncA gene showed
the highest mutational diversity: 29 mutations, two of
which occurring on the promoter region (Table 3).
Comparing the mutations found across GC1 and
GC2 isolates to the complete Beijing dataset assembled
for this study (Supplementary Table S3) it is note-
worthy that: (i) the ethA 182delG and 887delA in ele-
ven GC2 and in six GC1 isolates, respectively, were
not found in any other Beijing isolates; (ii) the rpoB
V496A mutation was detected only in the GC1 sub-
branch encompassing PT000078 and PT000080; and
(iii) the pncA D63A was only detected in 17 isolates
across the entire dataset, eleven of which from GC2
and six from GC1. In contrast, rpoB S450L, katG
S315T and rpsL K43R mutations were highly prevalent
as these were detected in 1246 (77.8%), 1,392 (86.9%)
and 778 (48.6%) MDR isolates, respectively, and
thereby confirming these as the most prevalent
mutations in drug resistant isolates, particularly in
Table 3. Mutations detected across drug resistance associated genes in GC1 and GC2 isolates.
Druga Gene GC1 (n = 121) GC2 (n = 39)
INH ahpC G-48A (n = 1)
inhA C-15T (n = 4); C-34T (n = 4); T-8G (n = 2); S94A (n = 1)
katG S315T (n = 121) S315T (n = 39)
RIF rpoB 1349delCGinsTC (n = 18); 1365del3bp (n = 1); A286V (n = 1); A584G
(n = 2); R827C (n = 5); D435G (n = 2); E761G (n = 1); G836S (n = 1);
H835P (n = 1); I480V (n = 13); I491V (n = 4); L452P (n = 6); L731P
(n = 12); P45S (n = 2); S450L (n = 78); V496A (n = 6)
S450L (n = 39)
STR gidB E92D (n = 121) E92D (n = 39)
rpsL K43R (n = 121) K43R (n = 39)
EMB embA C-12T (n = 1) N722D (n = 1); C-16G (n = 11)
embB N296H (n = 4); D1024N (n = 1); D354A (n = 8); Q497R (n = 14);
Q497K (n = 3); G406A (n = 5); G406D (n = 4); G406C (n = 1); G406S
(n = 1); M306I (n = 28); M306V (n = 38); T643I (n = 1); Y319C
(n = 2)
M306V (n = 37); Y319S (n = 1)
ubiA I179T (n = 4); W175G (n = 1) T104A (n = 1)
PZA pncA 260insCC (n = 1); 390delC (n = 2); D12A (n = 2); D136Y (n = 1); D63A
(n = 6); Q141P (n = 17); G108R (n = 1); G17V (n = 1); G78D (n = 1);
G97V (n = 1); H57R (n = 3); L116P (n = 1); L151S (n = 4); L172P (n
= 1); L4S (n = 13); L4W (n = 2); M1I (n = 1); M1T (n = 1); T114P (n =
1); T168P (n = 1); T47A (n = 2); W68R (n = 1); W68G (n = 1); Y64D
(n = 2); V139G (n = 1); V180A (n = 6); V7G (n = 2); A-11G (n = 2); G-
13T (n = 2)
188delG (n = 4); 352insG (n = 2); D63A (n = 11); G132S (n = 2); H51Y
(n = 1); I133T (n = 1); I6S (n = 2); L156P (n = 1); K96T (n = 1); V139L
(n = 1); V155G (n = 1); V163E (n = 1)
FQ gyrA 280del5bpins5bp (n = 1); 281del4bpins4bp (n = 13); A90V (n = 5);
E21Q (n = 121); G668D (n = 121); H52Y (n = 1); S447F (n = 4)
280del5bpins5bp (n = 1); 281del4bpins4bp (n = 7); E21Q (n = 39);
G668D (n = 39)
SLID eis C-12T (n = 3); C-14T (n = 3); G-10A (n = 10); G-37T (n = 19) C-12T (n = 1); C-14T (n = 4); G-10A (n = 1)
rrs A1401G (n = 16) A1401G (n = 8)
ETH ethA 1012delA (n = 7); 113delT (n = 9); 511delT (n = 3); 705delA (n = 2);
828delC (n = 2); 887delA (n = 6); L440P (n = 5); F64V (n = 1);
W256Ter (n = 2); Y140Ter (n = 2); Y461C (n = 1)
182delG (n = 11); 945delG (n = 1); R207G (n = 2); Q254P (n = 1);
Q347Ter (n = 2); L62R (n = 4); T314I (n = 9); W391Ter (n = 2)
inhA C-15T (n = 4); C-34T (n = 4); T-8G (n = 2); S94A (n = 1)
DCS alr S22L (n = 1)
PAS folC I43T (n = 2); S150G (n = 1) E40G (n = 1)
thyA 654delC (n = 1) P253A (n = 12)
thyX C-16T (n = 1); C-19G (n = 1) C-16T (n = 11)
aDrug abbreviations: INH, isoniazid; RIF, rifampicin; STR, streptomycin; EMB, ethambutol; PZA, pyrazinamide; FQ, fluoroquinolones; SLID, second-line inject-
able drugs; ETH, ethionamide; DCS, D-cycloserine; PAS, para-aminosalicylic acid.
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former Soviet states [16]. Moreover, the thyX C-16T
and embA C-16G mutation were well represented in
eleven GC2 (28.2%) isolates whereas across MDR-TB
and in the entire dataset these mutations were detected
only in 62 (3.8%) MDR-TB isolates (total: 72 [1.4%]
across all isolates) for the thyX C-16T mutation and,
in 15 (0.9%) MDR-TB isolates (total: 17 [0.3%] across
all isolates) for the embA C-16G mutation.
Discussion
The increasing rates of MDR-TB and XDR-TB are a
major roadblock to the WHO TB Elimination goals.
Despite having the M. tuberculosis genetic diversity
characterized to different extents, Portugal and Gui-
nea-Bissau present different healthcare systems and
challenges regarding TB control. A common challenge
pertains the introduction and transmission of non-
endemic strains such as the Beijing family with no
study previously attempting to establish epidemiologi-
cal links between these countries and investigate the
routes by which these strains may be introduced in
the current epidemiological scenario of each country.
Most Beijing strains detected in Portugal and Gui-
nea-Bissau were in fact not clustered using classical
typing methods. This latter observation suggests recent
emergence of these strains, particularly in Portugal. A
higher degree of clustered Beijing isolates was observed
for Guinea-Bissau therefore suggesting ongoing trans-
mission of Beijing strains but the route by which
these strains were imported into Guinea-Bissau is
unclear as all patients were of Guinean nationality. It
is known that the Beijing is the predominant genotype
across Central, Eastern, South-Eastern Asia and North
Eurasia and, that it has been detected in Northern,
Eastern and Southern Africa [10,15]. This data suggests
that MDR-TB Beijing strains are now also emerging in
West African countries such as Guinea-Bissau.
To understand and place the origin of Beijing iso-
lates in Portugal and Guinea-Bissau in a broader epide-
miological context, we compiled a global dataset of
5,482 clinical isolates. Isolates belonging to superclus-
ters 100-32 and 94-32 were detected in Portugal and
Guinea-Bissau, respectively. Supercluster 100-32
(more specifically, its major B0/W148 variant) is highly
associated with MDR-TB in Russia [29] and is often
isolated from immigrants in Europe, whereas super-
cluster 94-32 (Central Asian/Russian clone), second
to 100-32 in Russia and less associated with MDR-
TB, is more prevalent in former Soviet Central Asia
[17]. Beyond these, the presence of types 2083-32,
4737-32 and 9387-32 in Portugal suggests other poss-
ible sources of Beijing strains. The presence of type
9124-32 in Guinea-Bissau is also suggestive of dissemi-
nation from Russia or eastern European countries,
where it is more prevalent. All clusters but type 9387-
32 had been previously associated with drug resistance
which stresses the ability of MDR-TB Beijing strains to
expand beyond its endemic settings. This initial analy-
sis based on cluster dispersion is indicative of different
possible sources for the Beijing strains in these settings.
One possible link between Guinea-Bissau and Russia
lies in the close bilateral relations that once existed
between former Soviet Union and Guinea-Bissau
which promoted scholarships for Guinean students
and military training in the Soviet Union. However,
the main limitation of this MIRU-VNTR based analysis
lies in its poor discriminatory power when compared to
WGS and poor ability to infer on the directionality of
the transmission dynamics. The fact that all MIRU-
VNTR clusters were defined based on 24-loci along
with a stringent definition of cluster based on comple-
tely similar profiles does limit the discordance between
methods [30]. Further discriminatory power could
have been obtained through the inclusion of 1980,
3232, 3820 and 4120 hypervariable VNTR loci since
the standardized 24-loci MIRU-VNTR typing
set alone is in many circumstances unable to resolve
closely related clones such as the 94-32 and 100-32
[31,32]. While the standard 24-loci set enabled the dis-
criminatory of the Beijing isolates in a non-endemic
setting such as Portugal, the inexistence of global data-
sets with hypervariable allelic also hampers global com-
parison using this classical typing method.
Nevertheless, WGS did allow for a more resolved
scenario in a global context and, enabled the identifi-
cation of two genomic clusters, herein named GC1
and GC2, that included isolates sequenced in this
study. In fact, GC2 encompassed a cross-border clus-
tering event between Portugal, Guinea-Bissau and
Brazil, with the number of immigrants and arrivals
from Guinea-Bissau to Portugal alerting for a pre-
viously unrecognized source of MDR-TB Beijing
strains in this country [11]. Moreover, the phyloge-
netic context of GC2 further demonstrated that
emergence of MDR-TB Beijing in Guinea-Bissau is
likely driven from strains imported from Eastern
Europe or former Soviet countries to Guinea-Bissau
and later mobilized to other Portuguese-speaking
countries. Interestingly, GC2 is herein shown to be
part of the Central Asia Outbreak clade which is a
specific sub-branch of the Central Asia clade, more
associated with MDR-TB and extensive geographic
dissemination beyond its place of origin [33]. Contra-
rily to GC2, GC1 shows a widespread distribution
across Central Asia and Europe and, has been
detected in Portugal as a result of two separate and
independent dissemination events: (i) one involving
four cases, two of which detected in the present
study, that given the apparent genetic distances
suggest clonal expansion already in Portugal but
whose original geographical source is unknown; and
(ii) a single case phylogenetically nested within
strains isolated in Tajikistan and Moldova that may
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have spread into Europe via other former Soviet
countries. In fact, GC1 appears to be dominated by
strains circulating within former Soviet states, com-
prising a reservoir of MDR-TB Beijing strains emer-
ging in Europe and likely to be part of Clade B/
East-Europe2/B0-W148 cluster [6,16,34]. The muta-
tional diversity associated with GC1 corroborates its
extensive dissemination and multiple evolutionary
trajectories leading to resistance amplification
towards XDR-TB from a common ancestor already
resistant to INH and STR. This observation is also
corroborated by the detection of different XDR-TB
and pre-XDR-TB Beijing strains in Spain among
sex workers, one of which (BJR1/ERR1665402)
herein found to belong to GC1 [35]. While the latter
did not disseminate in the community, GC1 second-
ary cases occurring in Portugal are herein observed
and, stress the importance of screening and prompt
access to TB care for immigrants [36].
The phylogenetic context of the non-clustered iso-
lates suggests that the three non-clustered isolates
from Portugal are representative of strains that appear
to circulate mostly in East Asian countries such as
China and Vietnam. Also, the same can be said for
the single Guinea-Bissau non-clustered isolate
although this isolate appears to represent an entire
clade disseminating across Africa but more deeply
rooted across Asian countries. The migrant population
in Guinea-Bissau (n = 1933, according to the last popu-
lation census in 2009) is mostly comprised of immi-
grants from Western African countries which can
pose as vehicle for the dissemination of these strains
but the migration profile of the country is poorly
characterized [37]. Portugal on the other hand has
observed a steep increase in the foreign population
with residency status originating from Asia: from
24,269, in 2007, to 54,508 legal residents in 2017
[38]. The emergence of non-clustered Beijing strains
in Portugal can therefore result from the increasing
international migratory flow from high-prevalence set-
tings for Beijing strains other than Eastern European
countries.
In conclusion, the present study corroborates the
emergence of MDR-TB Beijing strains in Portugal
and Guinea-Bissau linked with former Soviet
Countries, as well as previously unidentified cross-
border clustering between Guinea-Bissau and Portu-
gal concerning the epidemiology of MDR-TB Beijing
strains. The latter is of special concern as the Luso-
phone migratory system may constitute an additional
gateway for intercontinental dissemination of MDR-
TB Beijing strains to countries such as Brazil or
Angola, that appear to have a very low prevalence
of Beijing strains. Also, we stress the role of WGS
as a high-resolution typing tool that can assist the
tracking of international relevant clones and its
transmission dynamics.
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